Vacant buildings cast doubt on Government’s pledge to make Britain a life sciences ‘superpower’
Vacant buildings cast doubt on Government’s pledge to make Britain a life sciences ‘superpower’
Copy link
GSK pledges $30bn US investment as UK's pharma woes deepen
UK drug price rises 'necessary', says Lord Patrick Vallance
New vaccine factory could produce 100 million doses a year
Mounjaro manufacturer blasts UK as ‘worst country in Europe’ for drug prices
Government’s plans in disarray before Trump talks as MSD, Eli Lilly and AstraZeneca moves prompt job fears
Merck criticises ‘successive UK governments’ as it cancels King’s Cross development
The pricing standoff between government and industry has stalled research and put thousands of jobs at risk
Under this incompetent Government, the UK is far from the ‘most attractive place to invest in the world’
Merck, known as MSD in Europe, criticised the UK’s business environment despite the government saying it has become ‘the most…
Sanofi’s market access chief urges ministers to come up with a roadmap to raise spending on new treatments
